Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells

Diabetes

Volumn 45, Issue 2, 1996, Pages 257-261

  Moens, Karen ^b   Heimberg, Harry ^b   Flamez, Daisy ^b   Huypens, Peter ^b   Quartier, Erik ^b   Ling, Zhidong ^b   Pipeleers, Daniel ^b   Gremlich, Sandrine ^b   Thorens, Bernard ^b   Schuit, Frans ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIC AMP; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCAGON RECEPTOR; HORMONE RECEPTOR; MESSENGER RNA; PANCREAS HORMONE; SECRETIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLUCAGONOMA; INSULINOMA; MALE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

EID: 13344293675     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.2.257     Document Type: Article

References (34)

1. Pipeleers DG, Schuit FC, in't Veld PA, Maes E, Hooghe-Peters EL, Van De Winkel M, Gepts W: Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology 117:824-833, 1985
2. Prentki M, Matschinsky FM: Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 67:1185-1248, 1987
3. Schuit FC, Pipeleers DG: Regulation of adenosine 3′, 5′-monophosphate levels in the pancreatic β cell. Endocrinology 117:834-840, 1985
4. Weir GC, Mojsov S, Hendrick GK, Habener JF: Glucagon-like peptide I (7-37) actions on endocrine pancreas Diabetes 38:338-342, 1989
5. Creutzfeldt W: The incretin concept today. Diabetologia 10:15-85, 1979
6. Kawai K, Yokota C, Ohashi S, Watanabe Y, Yamashita K: Evidence that glucagon stimulates insulin secretion through its own receptor in rats Diabetologia 38:274-270, 1995
7. Bonner-Weir S, Orci L: New perspective on the microvasculature of the islets of Langerhans in the rat Diabetes 31:883-889, 1982
8. Van Schravendijk CFH, Foriers A, Ilooghe-Peters EL, Rogiers V, De Meyts P, Sodoyez JC, Pipeleers DG: Pancreatic hormone receptors on islet cells Endocrinology 117:841-848, 1985
9. Kofod H, Adelhorst K, Christensen LB, Fuhlendorff J, Godtfredsen SE, Kirk O, Lundgren K: Beta-cells do not have glucagon receptors but GLP-1 receptors! Digestion 54:346-347, 1993
10. Abrahamsen N, Nishimura E: Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3′,5′-monophosphate, and glucocorticoids. Endocrinology 136:1572-1578, 1995
11. Jelinek LJ, Lok S, Rosenberg GB, Smith RA, Grant FJ, Biggs S, Bensch PA, Kuijper JL, Sheppard PO, Sprecher CA, O'Hara PJ, Foster D, Walker KM, Chen LHJ, McKernan PA, Kindsvogel W: Expression cloning and signaling properties of the rat glucagon receptor. Science 259:1614-1616, 1993
12. Thorens B: Expression cloning of the pancreatic B-cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89 8641-8645, 1992
13. Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133:2861-2870, 1993
14. Holz IV GG, Kuhtreiber WM, Habener JF: Pancreatic beta-cells are rendered glucose-competent by insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361:362-365, 1993
15. Kiekens R, in't Veld P, Mahler T, Schuit F, Van de Winkel M, Pipeleers D: Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity. J Clin Invest 89:117-125, 1992
16. Pipeleers DG, in't Veld P, Van De Winkel M, Maes E, Schuit FC, Gepts W: A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117:806-816, 1985
17. Thorens B, Sarkar HK, Lodish HR: Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and β-pancreatic islet cells. Cell 55:281-290, 1988
18. Widmann C, Dolci W, Thorens B: Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas. Biochem J 310 203-214, 1995
19. Madsen OD, Karlsen C, Nielsen E, Lund K, Kofod H, Welinder B, Rehfeld JF, Larsson LI, Steiner DF, Holst JJ, Michelsen BK: The dissociation of tumor-induced weight loss from hypoglycemia in a transplantable pluripotent rat islet tumor results in the segregation of stable α- and β-cell tumor phenotypes. Endocrinology 133:2022-2030, 1993
20. Schuit FC, Derde MP, Pipeleers DG: Sensitivity of pancreatic A and B cells to somatostatin. Diabetologia 32:207-212, 1989
21. Kato I, Suzuki Y, Akabane A, Yonekura H, Tanaka O, Kondo H, Takasawa S, Yoshimoto T, Okamoto H: Transgenic mice overexpressing human vasoactive intestinal peptide (VIP) gene in pancreatic β cells. J Biol Chem 269:21223-21228, 1994
22. Yada T, Sakurada M, Ihida K, Nakata M, Murata F, Arimura A, Kikuchi M: Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet β-cells. J Biol Chem 269.1290-1293, 1994
23. Schuit FC, in't Veld PA, Pipeleers DG: Glucose stimulates insulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc Natl Acad Sci USA 85.3865-3869, 1988
24. Heimberg H, De Vos A, Vandercammen A, Van Schaftingen E, Pipeleers D, Schuit F: Heterogeneity in glucose sensitivity among pancreatic B-cells is correlated to differences in glucose phosphorylation rather than glucose transport. EMBO J 12:2873-2879, 1993
25. Kolligs F, Fehmann H-C, Göke R, Göke B: Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin(9-39)amide Diabetes 44:16-19, 1995
26. Roberge JN, Brubaker PL: Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 133:233-240, 1993
27. Ebert R, Unger H, Creutzfeldt W: Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption. Diabetologia 24:449-454, 1993
28. Fehmann HC, Göke B, Göke R, Trautmann ME, Arnold R: Synergistic stimulatory effect of glucagon-like peptide-1(7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas. FEBS Lett 252:109-112, 1989
29. Gutniak M, Orskov C, Holst JJ, Ahrén B, Efendic S: Antidiabetogenic effects of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-1322, 1992
30. Fehmann HC, Habener JF: Functional receptors for the insulinotropic hormone glucagon-hke peptide-I(7-37) on a somatostatin secreting cell line. FEBS Lett 279:335-340, 1991
31. Pederson RA, Brown JC: Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas. Endocrinology 103. 610-615, 1978
32. Suzuki S, Kawai K, Ohasni S, Mukai H, Murayama Y, Yamashita K: Reduced insulinotropic effects of glucagon-like peptide-1-(7-36)amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas. Diabetes 38:741-744, 1990
33. Pipeleers DG, Schuit FC, Van Schravendijk CFH, Van De Winkel M: Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 117:817-823, 1985
34. Schuit FC, Pipeleers DG: Differences in adrenergic recognition by pancreatic A and B cells Science 232:875-877, 1986